(Q34751899)

4 August 2017

title

Which bioequivalence study for a racemic drug? Application to milnacipran (English)

1 reference

4 August 2017

Deprez D

1

1 reference

4 August 2017

Chassard D

2

1 reference

4 August 2017

Baille P

3

1 reference

4 August 2017

Mignot A

4

1 reference

4 August 2017

Ung HL

5

1 reference

4 August 2017

Puozzo C

6

1 reference

4 August 2017

publication date

1 April 1998

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

4 August 2017

published in

1 reference

4 August 2017

volume

23

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

166-171

1 reference

Controversies in Bioequivalence Studies

4 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03189334

Enantioselective versus non-enantioselective assays in comparative bioavailability studies with racemic drugs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9725476

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9725476

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reference weights. Practical considerations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9725476

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF03189334

1 reference

Dimensions Publication ID

4 August 2017

1012906826

0 references

1 reference